Effects of timolol and dorzolamide on ocular blood flow in patients with open angle glaucoma and ocular hypertension

被引：0
|
作者：
Schmetterer, L [1 ]
Fuchsjaeger-Mayrl, G [1 ]
Kolodjaschna, J [1 ]
Mensah, TA [1 ]
Rainer, G [1 ]
Georgopoulos, M [1 ]
Kircher, K [1 ]
Buehl, W [1 ]
Vass, C [1 ]
机构：
[1] Univ Vienna, A-1010 Vienna, Austria
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2003年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
137
引用
收藏
页码：U24 / U24
页数：1
相关论文
共 50 条
  • [31] A comparison of the ocular hypotensive effect of dorzolamide hydrochloride/timolol maleate to that of the concomitant therapy with brimonidine tartate and timolol malcate in patients with ocular hypertension or primary open-angle glaucoma.
    Sall, KN
    Johnson-Pratt, L
    Skobieranda, F
    Polis, A
    DeLucca, P
    Kolodny, A
    Fletcher, C
    Cassel, D
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S822 - S822
  • [32] Hypotensive efficacy in primary open-angle glaucoma and ocular hypertension: latanoprost in monotherapy vs timolol and dorzolamide in association
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2000, 78 : 49 - 50
  • [33] Tolerability and efficacy of dorzolamide versus acetazolamide in patients with ocular hypertension or open-angle glaucoma
    Stewart, WC
    Halper, LK
    Najarian, D
    Johnson-pratt, L
    Hartenbaum, D
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S664 - S664
  • [34] Comparison of dorzolamide and pilocarpine as adjunctive therapy in patients with open-angle glaucoma and ocular hypertension
    Hartenbaum, D
    Maloney, S
    Vaccarelli, L
    Liss, C
    Wilson, H
    Gormley, GJ
    CLINICAL THERAPEUTICS, 1999, 21 (09) : 1533 - 1538
  • [35] Efficacy and safety of unoprostone, dorzolamide, and brimonidine in adjunctive therapy to timolol in patients with primary open-angle glaucoma and ocular hypertension.
    Hommer, AB
    Mertz, B
    Schwenninger, C
    Yannoulis, N
    Kapik, B
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S554 - S554
  • [36] Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension
    Orzalesi, N
    Rossetti, L
    Invernizzi, T
    Bottoli, A
    Autelitano, A
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (09) : 2566 - 2573
  • [37] Fixed combination dorzolamide-timolol in the treatment of ocular hypertension and glaucoma
    Khouri, Albert S.
    Fechtner, Robert D.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2007, 2 (05) : 711 - 717
  • [38] The Safety and Efficacy of Brinzolamide 1%/Timolol 0.5% Fixed Combination Versus Dorzolamide 2%/Timolol 0.5% in Patients With Open-angle Glaucoma or Ocular Hypertension
    Manni, Gianluca
    Denis, Phillipe
    Chew, Paul
    Sharpe, Elisabeth D.
    Orengo-Nania, Silvia
    Coote, Michael A.
    Laganovska, Guna
    Volksone, Lasma
    Zeyen, Thierry
    Filatori, Isabella
    James, John
    Aung, Tin
    JOURNAL OF GLAUCOMA, 2009, 18 (04) : 293 - 300
  • [39] The Safety and Efficacy of Brinzolamide 1%/Timolol 0.5% Fixed Combination Versus Dorzolamide 2%/Timolol 0.5% in Patients with Open-Angle Glaucoma or Ocular Hypertension
    Akcay, Betul Ilkay Sezgin
    Guney, Esra
    Bozkurt, Kansu Tahir
    Unlu, Cihan
    Akcali, Gulunay
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, 29 (10) : 882 - 886
  • [40] Brinzolamide/timolol fixed combination for open-angle glaucoma and ocular hypertension
    Hollo, Gabor
    EXPERT REVIEW OF OPHTHALMOLOGY, 2009, 4 (02) : 129 - 133
12345